Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPear Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2023 | Q4 2022 | -$0.22 | $0.21 | 0.43 | $2.57 M | |
| 11/14/2022 | Q3 2022 | -$0.21 | -$0.25 | -0.04 | $4.08 M | |
| 08/11/2022 | Q2 2022 | -$0.25 | $0.30 | 0.55 | $3.30 M | |
| 05/16/2022 | Q1 2022 | -$0.24 | -$0.09 | 0.15 | $2.75 M | |
| 03/28/2022 | Q4 2021 | -$0.67 | $4.21 M | |||
| 11/04/2021 | Q3 2021 | $0.21 | $0 | |||
| 08/19/2021 | Q2 2021 | -$0.34 | $0 | |||
| 05/24/2021 | Q1 2021 | $0.07 | $0 |
Pear Therapeutics, Inc. Earnings: FAQ's
When is Pear Therapeutics, Inc.'s earnings date?
Pear Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates.
Did Pear Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Pear Therapeutics, Inc. (:PEAR) reported $0.2078 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.4278.
How can I listen to Pear Therapeutics, Inc.'s earnings conference
call?
The conference call for Pear Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Pear Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Pear Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Pear Therapeutics, Inc. generate each year?
Pear Therapeutics, Inc. (:PEAR) has a recorded annual revenue of $12.69 M.
How much profit does Pear Therapeutics, Inc. generate each year?
Pear Therapeutics, Inc. (:PEAR) has a recorded net income of $12.69 M. Pear Therapeutics, Inc. has generated $-0.17 earnings per share over the last four quarters.
What is Pear Therapeutics, Inc.'s price-to-earnings ratio?
Pear Therapeutics, Inc. (:PEAR) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is -0.